Here are four takeaways:
1. The presentations included:
- One year results of an international multi-center study of EndoStim therapy for refractory GERD
- Interim results from EndoStim’s international patient registry
- Four year outcomes of EndoStim therapy
- Effect of EndoStim on reflux mechanisms in GERD patients
2. Also presented was an additional independent study examining under-diagnosed and inadequately-treated GERD patients, titled “Inadequate Symptom Control on Long-Term PPI Therapy in GERD – Fact or Fiction?”.
3. EndoStim developed a minimally-invasive implant that restores normal esophageal function through neurostimulation.
4. The United States has not approved the EndoStim system.
More articles on GI & endoscopy:
Dr. Kenneth Chang performs 1st TIF procedure using new EsophyX Z device: 6 things to know
Double reprocessing duodenoscopes reduces infection transmission risk: 4 insights from new research
Early cancer detection found with free colonoscopies — 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
